Novavax (NVAX) Cash from Investing Activities (2010 - 2026)

Novavax's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$28.4 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 61.32% year-over-year to -$28.4 million in Q1 2026; TTM through Mar 2026 was -$33.3 million, a 87.67% increase from a year earlier, with the FY2025 full-year figure at -$78.3 million, up 61.64% from the prior year.
• Cash from Investing Activities slipped to -$28.4 million in Q1 2026 per NVAX's latest filing, from $20.5 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $144.0 million in Q4 2024 and bottomed at -$372.7 million in Q2 2024.
• The 5-year median for Cash from Investing Activities is -$18.4 million (2023), against an average of -$27.2 million.
• Biggest YoY gain for Cash from Investing Activities was 1686.33% in 2024; the steepest drop was 4691.19% in 2024.
• Year by year, Cash from Investing Activities stood at -$22.1 million in 2022, then surged by 58.86% to -$9.1 million in 2023, then soared by 1686.33% to $144.0 million in 2024, then tumbled by 85.78% to $20.5 million in 2025, then sank by 238.46% to -$28.4 million in 2026.
• Per Business Quant, the three latest NVAX Cash from Investing Activities figures stand at -$28.4 million (Q1 2026), $20.5 million (Q4 2025), and -$136.5 million (Q3 2025).